Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening-Reference-Cited by-同舟云学术

Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening

Author:

de Oliveira Osmair Vital¹,Rocha Gerd B.²,Paluch Andrew S.³^ORCID,Costa Luciano T.⁴

Affiliation:

1. Instituto Federal de Educação, Ciência e Tecnologia de São Paulo, Catanduva, SP, Brasil

2. Departamento de Química, Universidade Federal da Paraíba, Cidade Universitária, João Pessoa, PB, Brasil

3. Department of Chemical, Paper, and Biomedical Engineering, Miami University, Oxford, OH, USA

4. MolMod-CS, Instituto de Química, Universidade Federal Fluminense - Outeiro de São João Batista, Niterói, Rio de Janeiro, Brazil

Funder

FAPESP

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil

Brazilian National Council for Scientific and Technological Development

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

Reference50 articles.

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献